| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Research and development | $10.2M-39.8% | $17.0M+0.8% | $16.8M+19.7% | $14.1M |
| General and administrative | $9.7M-23.6% | $12.6M-6.5% | $13.5M-6.6% | $14.5M |
| Severance and related charges | $0-100.0% | $1.1M | $0 | — |
| Total operating expenses | $19.9M-35.2% | $30.7M+1.1% | $30.3M+6.4% | $28.5M |
| Interest income | $421K+83.0% | $230K | $0 | — |
| Loss from operations | -$19.4M+36.1% | -$30.4M-1.4% | -$30.0M-5.2% | -$28.5M |
| Net loss | -$19.4M+36.1% | -$30.4M-1.4% | -$30.0M-5.2% | -$28.5M |
| Net loss per share - basic | -$4440.00+74.0% | -$17050.00-1605.0% | -$1000.00+26.5% | -$1360.00 |
| Net loss per share - diluted | -$4440.00+74.0% | -$17050.00-1605.0% | -$1000.00+26.5% | -$1360.00 |
| Weighted-average number of shares used in computing net loss per common share - basic | $4374328000.00+145.1% | $1784890000.00-94.0% | $29864932000.00+42.4% | $20967955000.00 |
| Weighted average number of shares used in computing net loss per share - diluted | $4374328000.00-91.8% | $53547030000.00+79.3% | $29864932000.00+42.4% | $20967955000.00 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.